Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 28, 16:00
439.90
-5.2 (-1.17%)
VOLUME 34,377
LIVE
NSE
Apr 28, 15:58
440.25
-3.45 (-0.78%)
VOLUME 363,266
News on Cadila Healthcare
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Zydus Cadila gets USFDA nod for anti-hypertensive tablets

2.36 pm | 25 Apr 2017 |  Source: PTI

The company has received "final approval from the United States Food and Drug Administration (USFDA) to market olmesartan medoxomil tablets in the str...

Zydus receives final approval from USFDA for Olmesartan Medoxomil tablets

1.54 pm | 25 Apr 2017 |  Source: Moneycontrol.com

Zydus Cadila has received final approval from the USFDA to market Olmesartan Medoxomil tablets in strength of 5 mg, 20 mg and 40 mg....

Cadila Q4 PAT seen up 19.5% to Rs 309.7 cr: ICICI Securities

1.13 pm | 17 Apr 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.8 percent Q-o-Q (down 0.4 percent Y-o-Y) to Rs 2434.2 crore, according to ICICI Securities. Cadila to report n...

Cadila Q4 PAT seen up 19.5% to Rs 309.7 cr: ICICI Securities

1.13 pm | 17 Apr 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.8 percent Q-o-Q (down 0.4 percent Y-o-Y) to Rs 2434.2 crore, according to ICICI Securities. Cadila to report n...

USFDA completes inspection of Cadila's Changodar plant

5.19 pm | 07 Apr 2017 |  Source: PTI

Drug firm Cadila Healthcare today said the USFDA has completed inspection of its manufacturing plant at Changodar with "no observation"....

Buy Cadila Healthcare, sell Infosys: Mitessh Thakkar 

2.41 pm | 07 Apr 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com is of the view that one can buy Cadila Healthcare and sell Infosys....

Cadila's Topical manufacturing facility successfully completes USFDA inspection

2.37 pm | 07 Apr 2017 |  Source: Moneycontrol.com

Cadila Healthcare has informed that the USFDA inspected its Topical manufacturing facility at Changodar, near Ahmadabad from April 3 to 7, 2017. At th...

Sun Pharma, Cadila Healthcare recall products from US market

5.26 pm | 30 Mar 2017 |  Source: PTI

Sun Pharma and Cadila Healthcare are recalling one product each from the US market due to contamination and presence of "foreign" tablets respectively...

'Even in US and Europe, we haven't seen such orchestrated action by pharma cos'

9.14 am | 21 Mar 2017 |  Source: Moneycontrol.com

In an interview to Moneycontrol, David Keeling of McKinsey & Co says Indian pharmaceutical companies have made a lot of progress in terms of quality c...

Hold Cadila Healthcare; target of Rs 400: Axis Direct

6.01 pm | 28 Feb 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Cadila Healthcare with a target price of Rs 400 in its research report dated February 27, 2017....

Hold Cadila Healthcare; target of Rs 425: ICICI Direct

3.26 pm | 21 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 425 in its research report dated February 17, 2017....

Buy Cadila Healthcare; target of Rs 510: Motilal Oswal

3.14 pm | 21 Feb 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 510 in its research report dated Febru...

Buy Cadila Healthcare; target of Rs 460: Edelweiss

3.55 pm | 02 Feb 2017 |  Source: Moneycontrol.com

Edelweiss is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 460 in its research report dated January 3...

Hold Cadila Healthcare; target of Rs 380: ICICI Direct

3.44 pm | 02 Feb 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cadila Healthcare with a target price of Rs 380 in its research report dated February 01, 2017....

Buy Cadila; target of Rs 385: HDFC Securities

3.23 pm | 02 Feb 2017 |  Source: Moneycontrol.com

HDFC Securities is bullish on Cadila has recommended buy rating on the stock with a target price of Rs 385 in its research report dated January 31, 20...

Hold Cadila Healthcare; target of Rs 392: Karvy

5.23 pm | 01 Feb 2017 |  Source: Moneycontrol.com

Karvy recommended hold rating on Cadila Healthcare with a target price of Rs 392 in its research report dated February 01, 2017....

Buy Cadila Healthcare; target of Rs 410: KR Choksey

5.06 pm | 01 Feb 2017 |  Source: Moneycontrol.com

KR Choksey is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 410 in its research report dated February...

Buy Cadila Health; target of Rs 425: Motilal Oswal

11.26 am | 01 Feb 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Health has recommended buy rating on the stock with a target price of Rs 425 in its research report dated January 3...

Cadila Healthcare shares down 7% post Q3 results

6.08 pm | 31 Jan 2017 |  Source: PTI

Shares of Cadila Healthcare fell 7 per cent after the drug firm reported a 34.58 per cent dip in consolidated net profit for the December quarter....

Cadila Q3 profit tanks 35% to Rs 282 cr on weak operating income

12.31 pm | 31 Jan 2017 |  Source: Moneycontrol.com

Operating profit during the quarter plunged 31.7 percent to Rs 404.3 crore and margin contracted sharply by 750 basis points to 17.1 percent compared ...

1 2 3 4 5
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.